Cardiology

Gili Pro BioSensor (also known as “Gili BioSensor System”)

ContinUse Biometrics Ltd.

FDA-cleared AI medical device

The device uses an optical sensor system and software algorithms to obtain and analyze video signal and estimate pulse rate, heart rate, respiratory rate and/or breathing rates. This device is not intended to independently direct therapy.

FDA Submission Metadata

Submission number
DEN200038
Decision date
April 2021
FDA panel
Cardiovascular
Product code
QOK
Clinical task (npj)
quantification/feature localization
Data modality (npj)
Images

This entry is sourced from the FDA AI/ML-Enabled Medical Devices list. No editorial review yet — the catalogue may add a deeper review of this device in future.

View on FDA ›

This entry is on our editorial review queue. Full evaluation — performance metrics, clinical evidence, safety record — lands as our review pipeline graduates each device. The information above is what's been verified to date.